Description
DOXOSIGN 400 TAB is a powerful bronchodilator containing Doxofylline 400 mg, a xanthine derivative that helps ease breathing in individuals with asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. Unlike theophylline, Doxofylline has minimal cardiac and gastrointestinal side effects, making it a safer long-term therapy option.
It works by relaxing bronchial smooth muscles, improving airflow, and reducing resistance in the respiratory tract.
Therapeutic Uses:
Bronchial asthma
Chronic obstructive pulmonary disease (COPD)
Acute and chronic bronchitis
Allergic bronchospasm
Adjunct to inhalation therapy in maintenance of lung function
Key Benefits:
Relieves bronchospasm and improves breathing
Lower risk of side effects compared to theophylline
Longer duration of action for improved compliance
Safe for use in adults and elderly patients
Can be used in monotherapy or combination therapy
DOXOSIGN 400 TAB is manufactured under strict WHO-GMP and ISO-certified conditions and exported internationally by BLUEPILL EXPRESS, a leading pharmaceutical supplier. The company ensures global distribution across Asia, Africa, Europe, the Middle East, and Latin America, with regulatory support and reliable delivery services.
